Supplementary Table S1 from Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations

Supplementary Table S1. pY peptides identified by phosphoproteomics in two DDR2 mutation cell line treated with or without 500 nM dasatinib for 3 hour (543, 636 pY peptides in H2286 and HCC366, respectively).